Treatment with oxoglaucine can enhance host resistance to Candida albicans infection of mice with adjuvant arthritis

Diagnostic Microbiology and Infectious Disease

Volumn 38, Issue 1, 2000, Pages 17-20

  Ivanovska, Nina ^a   Hristova, Maria ^a  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN; OXOGLAUCINE; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT ARTHRITIS; AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG INHIBITION; FEMALE; HOST RESISTANCE; IMMUNOSTIMULATION; LYMPHOCYTE CLONE; LYMPHOCYTE COUNT; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMAL; APOMORPHINE; ARTHRITIS, EXPERIMENTAL; BIOLOGICAL ASSAY; CANDIDA ALBICANS; CANDIDIASIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; MICE; TUMOR NECROSIS FACTOR;

EID: 0033802988     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(00)00167-X     Document Type: Article

References (12)

1. Carter L.L., Dutton R.W. Type 1 and Type 2 A fundamental dichotomy for all T-cell subsets . Curr Opinion Immunol. 8:1996;336-342.
2. χ is required for IL-12 responsiveness in mice with Candida albicans infection. J Immunol. 161:1998;3543-3550.
3. Charlton B., Lafferty K.J. The Th1/Th2 balance in autoimmunity. Curr Opinion Immunol. 7:1995;793-798.
4. Ivanovska N., Philipov S., Georgieva P. Immunopharmacological activity of aporphinoid alkaloid oxoglaucine. Pharmacol Res. 35:1997;267-272.
5. Ivanovska N., Philipov S. A low dose immunorestorative effect of aporphinoid alkaloid oxoglaucine on experimentally immunosuppressed and infected mice. Meth Find Exp Clin Pharmacol. 19:1997;579-583.
6. Ivanovska N., Hristova M., Philipov S. Immunosuppression and recovery of drug impaired host resistance against Candida albicans infection by oxoglaucine. Pharmacol Res. 41:2000;99-105.
7. Kerksiek K.M., Pamer E.G. T cell responses to bacterial infection. Curr Opinion Immunol. 11:1999;400-405.
8. Kollias G., Douni E., Kassiotis G., Dimitris K. On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol Rev. 169:1999;175-194.
9. Mencacci A., Cenci E., Bistoni F., Bacci A., Del Sero G., Montagnoli C., Fè d'Ostiani C., Romani L. Specific and nonspecific immunity to Candida albicans a lesson from genetically modified animals . Res Immunol. 149:1998;352-361.
10. Romani L., Mencacci A., Tonnetti L., Spaccapelo R., Cenci E., Puccetti P., Wolf S.F., Bistoni F. Interleukin-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J Immunol. 153:1994;5157-5175.
11. Romani L., Mencacci A., Cenci E., Spaccapelo R., Toniatti C., Puccetti P., Bistoni F., Ploi V. Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin-6-deficient mice infected with Candida albicans. J Exp Med. 183:1996;1-11.
12. Sakaguchi S., Toda M., Asano M., Itoh M., Morse S.S., Sakaguchi N. T cell-mediated maintenance of natural self-tolerance its breakdown as a possible cause of various autoimmune diseases . J Autoimmun. 9:1996;211-220.